Skip to main content

Osteoarthritis

Bella Mehta
@bella_mehta
Not every osteophyte means clinically important OA. Abst#1923 at #ACR26 - isolated grade 1 patellofemoral osteophytes were not linked to meaningful pain or progression, while grade ≥2 lesions were more clinically relevant. Important nuance for early OA definitions. @rheumnow
Adela Castro
@AdelaCastro222
ACR 2026 guidelines for management of OA 1. Self management programs: educate pts on the disease and involve them in their care. 2. PT/OT-Key! 3. Mobility aids if limited walking. 4. Exercise! all of them recommended. 5. Wt loss if hip/knee OA and overwt or obese 6. Topical https://t.co/JnbNaZ3CSw
Audrey Gibson
@Gibson_RheumPAC
Is an acidic joint environment accelerating OA? New translational research links joint acidosis to chondrocyte senescence, while GPR68 activation appears to attenuate senescence responses.A potential therapeutic target beyond pain relief! Yung et al. | #LB03 @RheumNow #ACR26
Audrey Gibson
@Gibson_RheumPAC
Conaghan et al. (TRIUMPH-4): Retatrutide 9 mg: weight -26.4% and WOMAC pain -4.48 at week 68; placebo: -2.1% and -2.43, respectively. A potentially important OA strategy. @rheumnow #ACR2026 Abstract#0871
Akhil Sood MD, MS
@AkhilSoodMD
Does GLP-1 use cut care use in knee OA? Abstract 1662 found GLP-1 use in pts with diabetes and knee OA: • No overall difference in health resource utilization (IRR 1.005) • Fewer inpatient days (IRR 0.412, about 59% fewer) • effect not observed after 9 months #ACR26 @rheumnow
Audrey Gibson
@Gibson_RheumPAC
TRIUMPH-4 • Conaghan et al. TRIUMPH-4: Retatrutide improved knee OA pain and weight at 68 weeks. What is the biggest implication for OA care? @rheumnow #ACR2026 Abstract#0871
Audrey Gibson
@Gibson_RheumPAC
Conaghan et al. (TRIUMPH-4): How much of knee OA pain improvement comes from unloading the joint vs metabolic effects? @rheumnow #ACR2026 Abstract#0871
Audrey Gibson
@Gibson_RheumPAC
Conaghan et al. (TRIUMPH-4): At 68 weeks, retatrutide 12 mg produced 28.7% mean weight loss vs 2.1% with placebo in adults with painful knee OA and excess weight. A striking metabolic signal with musculoskeletal implications. @rheumnow #ACR2026 Abstract#0871
Eric Dein
@ericdeinmd

DMARD in OA? #ACR26 @RheumNow Ab#0871 TRIUMPH-4 Retatrutide in Knee OA - GIP/GLP1/gluc rec ago 9mg/12 mg v PBO WOMAC reduction w16, sustained thro w68 Wt dec 29% (32 kg) at wk68 78% on RETA had 50%+ WOMAC pain improvement Discontinuation from AE -13/18%, 46% due to GI AE #ACRBest https://t.co/a9qGtZx5t9

×